Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Esserman

Showing results (161-170 of 308) with videos related to

Pageof 31
Sort By:
BMJ Open|February 17, 2025
National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modellingKimberly Badal, James Staib, Jeffrey A Tice, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2025
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast CancerEmmanuel F Petricoin, Denise M Wolf, Christina Yau, et al.
NPJ Breast Cancer|May 26, 2021
Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injectionAlexa C Glencer, Jasmine M Wong, Nola M Hylton, et al.
Breast Cancer Research and Treatment|May 16, 2017
Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapyA Jo Chien, Julia Chambers, Fiona Mcauley, et al.
The Breast Journal|August 4, 2009
Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancerJulie E Lang, Liang-Chih Liu, Ying Lu, et al.
Breast Cancer Research and Treatment|June 30, 2017
Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapyA Jo Chien, Julia Chambers, Fiona Mcauley, et al.
BMC Medical Genomics|November 19, 2020
Mutational profiling of micro-dissected pre-malignant lesions from archived specimensDaniela Nachmanson, Joseph Steward, Huazhen Yao, et al.
NPJ Breast Cancer|March 6, 2021
Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinomaMary Kathryn Abel, Heather Greenwood, Tatiana Kelil, et al.
Clinical Breast Cancer|January 24, 2017
Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast CancerElla F Jones, Kimberly M Ray, Wen Li, et al.
AJR. American Journal of Roentgenology|May 24, 2005
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survivalSavannah C Partridge, Jessica E Gibbs, Ying Lu, et al.
Pageof 31

Showing results (161-170 of 308) with videos related to

Sort By:
Pageof 31
BMJ Open|February 17, 2025
National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modellingKimberly Badal, James Staib, Jeffrey A Tice, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2025
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast CancerEmmanuel F Petricoin, Denise M Wolf, Christina Yau, et al.
NPJ Breast Cancer|May 26, 2021
Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injectionAlexa C Glencer, Jasmine M Wong, Nola M Hylton, et al.
Breast Cancer Research and Treatment|May 16, 2017
Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapyA Jo Chien, Julia Chambers, Fiona Mcauley, et al.
The Breast Journal|August 4, 2009
Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancerJulie E Lang, Liang-Chih Liu, Ying Lu, et al.
Breast Cancer Research and Treatment|June 30, 2017
Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapyA Jo Chien, Julia Chambers, Fiona Mcauley, et al.
BMC Medical Genomics|November 19, 2020
Mutational profiling of micro-dissected pre-malignant lesions from archived specimensDaniela Nachmanson, Joseph Steward, Huazhen Yao, et al.
NPJ Breast Cancer|March 6, 2021
Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinomaMary Kathryn Abel, Heather Greenwood, Tatiana Kelil, et al.
Clinical Breast Cancer|January 24, 2017
Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast CancerElla F Jones, Kimberly M Ray, Wen Li, et al.
AJR. American Journal of Roentgenology|May 24, 2005
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survivalSavannah C Partridge, Jessica E Gibbs, Ying Lu, et al.
Pageof 31